72 percent of low-income, uninsured, or publicly insured women perceived financial barriers to screening
TUESDAY, July 13, 2021 (HealthDay News) — Nearly three in four low-income women cite perceived substantial financial barriers to undergoing cervical cancer screening, according to a study recently published in the Journal of Women’s Health.
Caitlin B. Biddell, from the University of North Carolina at Chapel Hill, and colleagues surveyed 702 low-income, uninsured, or publicly insured women (aged 25 to 64 years) who were not up to date on cervical cancer screening according to national guidelines. Participants were questioned about perceived financial barriers and costs related to screening.
The researchers found that 72 percent of participants perceived financial barriers to screening, including screening appointment costs (71 percent), follow-up/future treatment costs (44 percent), lost pay due to time missed from work (6 percent), and transportation costs (5 percent). Perceived costs to screening were associated with being uninsured versus publicly insured, being younger (25 to 34 years versus 50 to 64 years), being White versus Black, and not reporting income data. The perceived out-of-pocket cost of screening ranged from $0 to $1,300, with a median expected cost of $245.
“Providing greater cost transparency and access to financial assistance may reduce perceived financial barriers to screening, potentially increasing screening uptake among this underserved population,” the authors write.
Several authors disclosed financial ties to medical technology and pharmaceutical companies.
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators
Addition of CAC to PREVENT-ASCVD Equations May Improve Predictive Utility in Certain Patients
Composite Dietary Antioxidant Index Inversely Linked to Cervical Cancer Prevalence
High-Value Program Involves Less Frequent Screens After HPV Vaccination
Sentinel Lymph Node Biopsy Noninferior to Lymphadenectomy in Cervical Cancer
Nonadherence to Cervical Cancer Screening Increased After COVID-19 Pandemic